Suppr超能文献

转移性骨肉瘤来源的外泌体 miR-675 通过靶向 CALN1 促进细胞迁移和侵袭。

Exosomal miR-675 from metastatic osteosarcoma promotes cell migration and invasion by targeting CALN1.

机构信息

Department of Orthopedics, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, PR China.

Shanghai Key Laboratory for Bone and Joint Diseases, Shanghai Institute of Orthopedics and Traumatology, Shanghai, 200025, PR China.

出版信息

Biochem Biophys Res Commun. 2018 Jun 2;500(2):170-176. doi: 10.1016/j.bbrc.2018.04.016. Epub 2018 Apr 11.

Abstract

Exosomal microRNAs(miRNAs) transfer from tumor to stromal cells is reportedly associated with cancer progression and metastasis in various epithelial cancers. However, the role of exosomal miRNA in the metastasis of osteosarcoma(OS) -the most common bone malignancy-still largely remains unknown. In this study, we purified exosomes with a median size close to 100 nm from cell culture media as well as patient serum, and proved that exosomes derived from the metastatic, but not the non-metastatic OS cells increase the migration and invasion of non-malignant fibroblast cells (hFOB1.19) in vitro. Furthermore, the differential miRNA cargo between metastatic and non-metastatic OS is identified by small RNA sequencing and RT-PCR validation, we found a highly expression of exosomal, but not cellular miR-675 level in the metastatic OS cell-lines compared with non-metastatic counterparts. Meanwhile, we also found that exosomal miR-675 could down-regulate CALN1 expression in recipient cell, which may influence the invasion and migration of hFOB1.19. Finally, the up regulation serum exosomal miR-675 and down regulation of CALN1 in tumor specimen was also found to be associated with the metastatic phenotype in OS patients. Our findings indicate that the exosomal miR-675 is a gene associated with OS and serum exosomal miR-675 expression may serve as a novel biomarker for the metastasis of OS.

摘要

外泌体 microRNAs(miRNAs)从肿瘤转移到基质细胞,据报道与各种上皮癌的癌症进展和转移有关。然而,外泌体 miRNA 在骨肉瘤(OS)转移中的作用——最常见的骨恶性肿瘤——仍然很大程度上未知。在这项研究中,我们从细胞培养介质和患者血清中纯化了大小接近 100nm 的中等大小的外泌体,并证明来自转移性而非非转移性 OS 细胞的外泌体增加了非恶性成纤维细胞(hFOB1.19)的体外迁移和侵袭。此外,通过小 RNA 测序和 RT-PCR 验证,确定了转移性和非转移性 OS 之间的差异 miRNA 负荷,我们发现与非转移性对应物相比,转移性 OS 细胞系中外泌体 miR-675 的表达水平较高,但细胞内 miR-675 的表达水平较低。同时,我们还发现外泌体 miR-675 可以下调受体细胞中 CALN1 的表达,这可能影响 hFOB1.19 的侵袭和迁移。最后,还发现肿瘤标本中血清外泌体 miR-675 的上调和 CALN1 的下调与 OS 患者的转移表型有关。我们的研究结果表明,外泌体 miR-675 是与 OS 相关的基因,血清外泌体 miR-675 表达可能成为 OS 转移的新型生物标志物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验